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CA VEAT EMPTOR: REGULATING THE ON-
LINE MEDICINE MAN IN THE NEW
FRONTIER
Patricia Stolf*
The explosion of technology and universal access to the Internet over
the past decade has created a global on-line marketplace at every person's
fingertips.' The Internet has become "a sprawling mall offering goods and
services"2 to even the most alienated in our society. Everyday, Internet
businesses are redefining and restructuring the distribution of goods and
services by finding creative ways to harness competition, sell products,
render services, disseminate information and gain access to new
consumers.3 In a society where time is precious and convenience is
essential, electronic commerce (e-commerce) is impacting all facets of life
- our economy, our relationships, our workplaces, our health, and our
* J.D. Candidate 2001, Columbus School of Law, The Catholic University of
America; B.A. 1995, University of Connecticut. The Author would like to thank
Mary Jo Carden for her invaluable editorial support and guidance.
1. ABA, Achieving Legal and Business Order in Cyberspace: A Report on
Global Jurisdiction Issues Created by the Internet (forthcoming 2000).
In recent years, the number of computers and users connected to the
Internet has skyrocketed as well. The number of computers hooked up
to the Internet globally in 1992 totaled only 1.3 million whereas currently
there are more than 68 million worldwide. Today, there are nearly 260
million users internationally with Internet access, and forecasts project
there will be over 765 million users by 2005. The number of Internet
users in the United States equaled 110 million at the end of 1999.
2. ACLU v. Reno, 521 U.S. 844, 853 (1997).
3. See Nancy Toross, Comment, Double Click on This. Keeping Pace with On
- line Market Manipulation, 32 Loy. L.A. L. REV. 1399 (1999); see also Brian K.
Epps, Maritz, Inc. v. Cybergold, Inc.: The Expansion of Personal Jurisdiction in the
Modern Age of Internet Advertising, 32 GA. L. REV. 237, 239 (1997) (quoting
Louise Kehoe, Surge of Business Interest, FIN. TIMES, Mar. 1, 1995, at XVIII); see
also Economic Perspective: Quarterly Economic and Market Analysis, First
Quarter 2000, at http://www.schroders.com (last visited July 2000) ("[W]hile the
Internet should result in a reduction in business costs it will also lead to increase in
competition. New companies can enter industries more easily. One issue will be
the extent to which people are prepared to trust the new businesses and execute
the transactions on line.").
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legal system.4
The vastness and newness of Internet development is creating a rapidly
evolving electronic medium in which it is difficult to ascertain distinct
legal boundaries. Regulated industries that "go global"5 must recognize
that they will reach numerous legal jurisdictions that may have different
or even conflicting regulatory requirements.6 The most notable regulated-
industry to proliferate onto the Internet is the on-line pharmacy business.7
A simple query on any web search engine will return hundreds of websites
that sell prescription drugs. It is estimated that over 500 electronic
businesses offer prescription drugs over the Internet. 8  "The on-line
pharmaceutical market is expected to grow from $11 million in 1998 to
$890 million in 2002, making it one of the fastest-growing e-commerce
industries." 9
This growth of "cyber-drugstores"1 ° has created grave concern within
the medical and legal communities regarding the safety and quality of
prescription drugs dispensed over the Internet. Public health officials are
"concerned about the Internet pharmacies that do not adhere to state
licensing requirements and standards and enable consumers to obtain
prescription drugs without a prescription and adequate physician
supervision."" While proponents of cyber-drugstores espouse the
convenience and cost effectiveness of ordering prescription drugs from a
personal computer in the comfort of one's home, critics point out the ease
of access to prescription and illegal drugs over the Internet.1 2 The risks
include receiving outdated, contaminated or inferior drugs, the possibility
of dangerous drug interactions, and children gaining access to dangerous
4. See The Impact of the Internet on the Mission of the Attorneys General:
Legal Challenges to Civil and Criminal Law Enforcement and Recommendations
for Action, at http://www.naag.org/features/legis.html (last visited Oct. 17, 2000).
5. Richard Raysman & Peter Brown, On-line Advertising and Marketing,
N.Y. L.J., Sept. 14, 1999, at 7.
6. See id. at 3.
7. See id.
8. F-D-C Reports, Inc., The Pink Sheet: FTC Surf Days Turn Up 500
Fraudulent Sites; Prescribing Sites Raise Concerns, 61(22) at 24 (May 31, 1999).
9. Christiane Truelove, The New Frontier, MED AD NEWS 18 (10) at 1 (Oct. 1,
1999).
10. Raysman, supra note 5, at 7.
11. U.S. GENERAL ACCOUNTING OFFICE, REPORT TO CONGRESSIONAL
REQUESTERS, INTERNET PHARMACIES ADDING DISCLOSURE REQUIREMENTS
WOULD AID STATE AND FEDERAL OVERSIGHT, GAO-01-69 (Oct. 2000)
[hereinafter GAO REPORT].
12. See Raysman, supra note 5, at 3.
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or inappropriate drugs, such as Viagra."3
These concerns are creating a jurisdictional and regulatory quagmire
that has ignited a debate over how to regulate the distribution and
purchase of prescription drugs over the Internet.14 Intrinsic in the on-line
pharmacy regulatory debate is the growing tension between the roles of
the federal and state governments as regulatory and enforcement
entities. 5
Traditionally, pharmacies operate in community settings subject to
state regulatory control boards." However, e-commerce is changing the
way pharmacies do business. In the contemporary electronic
marketplace, state laws regulating pharmacy practice run the risk of
having an extraterritorial effect on Internet companies outside a state's
legal jurisdiction. Through the Internet marketplace individuals can
easily access and order drugs from pharmacies unlicensed in a particular
state and receive the drugs across state borders through the mail. The
federal government's role in regulating pharmacy practice has remained
limited to the Food and Drug Administration's (FDA) role of ensuring
that prescription drug products are safe and effective for consumption by
17consumers.
The use of the Internet to sell and distribute drugs has created a
jurisdictional struggle between the authority of the federal government,
through the FDA, to regulate the quality and effectiveness of drugs and
the state's right to regulate and license pharmacy practice. Both the states
and the federal government are grappling with the challenge of balancing
the benefits of on-line pharmacies with the health and safety concerns of
the products dispensed to consumers. Unfortunately, ambiguity remains
as to what level of government has the authority to regulate entities
selling drugs over the Internet.
The current state-based system of regulation has established safeguards
13. See Jane E. Henney, Internet Purchase of Prescription Drugs: Buyer
Beware, 131 ANNALS OF INTERNAL MED. 861-62 (1999) (explaining that Viagra is a
popular drug for impotence, which if used incorrectly, can lead to severe health
consequences).
14. See generally Drugstores on the Net. The Benefits and Risks of On-line
Pharmacies; Hearing Before the Subcomm. on Oversight & Investigations on
Commerce of the House Committee on Commerce, 106th Cong. (1999) [hereinafter
House Hearing].
15. See id.
16. See Raysman, supra note 5, at 7.
17. See Federal Food Drug and Cosmetic Act of 1938 § 353(b)(1), as codified
21 U.S.C. § 503(b)(1) (1994).
2000]
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to ensure proper oversight and distribution of prescription drugs.18
However, the Internet easily bypasses these safeguards because it creates
ambiguous legal boundaries" and allows pharmacies and physicians to
anonymously reach across state borders to prescribe, sell, and dispense• 20
prescription drugs without complying with state regulations. Regulators
find themselves in a quandary over how to balance the current state-based
system of regulation while maintaining safety and professional standards
that allow consumers the flexibility and convenience of purchasing
prescription drugs on-line."
This Comment addresses how federal and state interests should be
balanced to meet the demands of pharmacy regulation in a technological
society. Part I presents a backdrop for the current regulatory debate by
providing an overview of the evolution of the current structure of federal
and state regulation of prescription drugs. Part II categorizes the
mechanisms of purchasing drugs on-line, with an emphasis on the benefits
and risks associated with the on-line purchasing of drugs. Part III
analyzes the federalism issues related to the regulation of the Internet and
in particular, on-line pharmacy licensing. Part IV examines the current
efforts by the pharmaceutical industry, the states and the federal
government to work within the existing legal boundaries to regulate on-
line pharmacies and suggests that a partnership between the federal and
state governments must be formed. Finally, this Comment culminates
with a proposal to uphold the original intent of Congress and the FDA to
create a pharmacy regulatory system to protect the consumer, while still
allowing federalism to flourish.
I. THE DEVELOPMENT OF DRUG REGULATION IN THE UNITED
STATES
In the last century, governments at all levels - federal, state, and local -
collaborated with the medical and pharmaceutical professions to create a
"risk-management system"22 that ensures patient and consumer• 23
protections, and medical quality by both doctors and apothecaries. This
risk-management regulatory system allows state and federal governments
18. See Henney, supra note 13.
19. See id.
20. See GAO REPORT, supra note 11.
21. See Issue Brief No. 752, Physician Connectivity: Electronic Prescribing
(National Health Policy Forum, The George Washington University) (2000).
22. PETER TEMIN, TAKING YOUR MEDICINE-DRUG REGULATION IN THE
UNITED STATES 48-50 (1980).
23. Id.
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to maintain separate and distinct roles with reference to licensing, drug
24
approval, and enforcement.
A. Federal Role in Pharmacy Regulation
Federal regulation of prescription drug distribution is controlled
primarily by the Food, Drug and Cosmetic Act (FDCA)25 and the
21Controlled Substance Act (CSA). Currently, several federal agencies
have concurrent jurisdiction over drug distribution in the United States.27
This comment will primarily focus on the background pertinent to
prescription drug distribution and the role of the FDA and the FDCA.
The FDCA, approved by Congress in 1938, provided a latticework for
the current infrastructure that regulates the prescribing, dispensing, and
distribution of prescription drugs in the United States." The FDCA led
to the development of the FDA and regulations that have evolved into
the government-regulated system of prescription drug distribution that we
have today. The United States Congress, the FDA, and the states have
moved from self-regulation by the consumer toward government-based
protection and regulation. 29 The FDA was created to guarantee the
effectiveness and safety of all available drugs.0 Congress assumed that
consumers could not understand the implications of a list of ingredients
and would not follow directions for proper use. 3' The FDCA was not
intended to deprive the consumer and medical profession of potent but
valuable drugs." Instead, the purpose of the FDCA and the FDA is to
ensure proper monitoring of prescription drugs by licensed doctors and• 3
safe distribution into the hands of consumers by licensed pharmacists.
This system created assurances of safety to the public, that any drug on
24. See Federal Food, Drug & Cosmetic Act, 21 U.S.C. § 301 (1994); see also
TEMIN, supra note 22, at 48-50.
25. Federal Food, Drug & Cosmetic Act, 21 U.S.C. § 301.
26. Federal Food, Drug & Cosmetic Act, 21 U.S.C. § 801 (1994).
27. The Food and Drug Administration (FDA), the Department of Justice
(DOJ), the Federal Trade Commission (FTC), the Drug Enforcement Agency
(DEA), the Customs Service and the Postal Service are the federal agencies that
have a role in the regulation of drugs.




32. See id. at 48-50.
33. See id.
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the market could be taken in reasonable quantities without harm.
4
In 1948, the Supreme Court also approved FDA oversight of the drug
regulatory system in United States v. Sullivan.35 Between 1951 and 1971,
the drug regulatory system evolved through congressional amendments
providing increased regulation and oversight by the FDA.36
These changes gave the FDA additional authority to approve the
introduction of new drugs into the market.37 Congress granted physicians
and pharmacists the ability to protect their patients from knowingly or
accidentally misusing medicines that are either toxic or have the potential
for causing harm.38 Accordingly, under the FDCA, prescription drugs
may now be distributed only with a valid prescription under the
professional supervision of a physician. 9  A prescription drug is
misbranded if it is not dispensed pursuant to a valid prescription in
accordance with 21 U.S.C. § 353(b).4
Violators of the FDCA can be charged either civilly or criminally.4' For
a felony conviction, the government must establish that the defendant
acted with intent to defraud or mislead either the consumer or the
government, or that the defendant is a repeat offender. Civil cases do
not require proof of intent to defraud.43
Congress also expanded the agency's authority by allowing it to create
and enforce standards of good manufacturing practices" for
pharmaceutical manufacturers and to enforce labeling laws.45 It also
extended the agency's administrative authority to withdraw approval that
it had previously granted to drugs for several reasons, such as safety
34. See id.
35. U.S. v. Sullivan, 332 U.S. 689, 694 (1948).
36. Congress made changes to the FDCA and the regulation and safety of
drugs through the Durham Humphrey Amendment, the 1962 Drug Amendments,
and additional regulatory actions by the FDA; TEMIN, supra note 22.
37. See TEMIN, supra note 22, at 48-50.
38. See House Hearing, supra note 14 (statement of Ivan K. Fong, Deputy
Assistant Att'y Gen., U.S. DOJ).
39. See Federal Food, Drug & Cosmetic Act, 21 U.S.C. § 353 (b)(1).
40. Federal Food, Drug & Cosmetic Act, 21 U.S.C § 353 (b).
41. See House Hearing, supra note 14 (statement of Ivan K. Fong, Deputy
Assistant Att'y Gen., U.S. DOJ).
42. Id.
43. Id.
44. See Pub. L. No. 87-781 (1962); see also TEMIN, supra note 22, at 48-50.
45. See id.
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concerns.4 However, the agency could not interfere with a doctor's right
to prescribe approved drugs for patients.
Currently, the FDCA47 requires that
(1) A drug intended for use by man which
(A) is a habit-forming drug to which 352(d) of this title applies;
or
(B) because of its toxicity or other potentiality for harmful
effect, or the method of its use, or the collateral measures
necessary to its use, is not safe for use except under the
supervision of a practitioner licensed by'law to administer
such drug; or
(C) is limited by an approved application under section 355 of
this title to use under the professional supervision of a
practitioner licensed by law to administer such drug. 8
The drug shall be dispensed only by prescription or authorized
prescription refill.
49
In addition to classifying and authorizing the sale of prescription drugs,
the FDA has the authority to allow drugs to be sold without a
prescription; these are known as over-the-counter drugs.5 ° Moreover, the
FDA statutorily regulates pharmaceutical importation, the sale or
distribution of an adulterated or misbranded drug, the sale or distribution
of an unapproved drug, the illegal promotion of a drug, the sale or
dispensing of a prescription drug without a valid prescription, and
counterfeit drugs."
The duties of the FDA, as outlined above, define the extent of the
FDA's current authority over the distribution of drugs. The FDA
establishes which drugs are obtainable over-the-counter and which drugs
52require a prescription from a licensed professional. However, the FDA
has never obtained any regulatory control over the licensure of
pharmacists or doctors. Throughout the entire regulatory debate these
responsibilities remained with the states. As a result, the states maintain
their rights to regulate, monitor, and license the professionals who have
dispensing and prescribing privileges.
46. See id.
47. Federal Food, Drug & Cosmetic Act, 21 U.S.C. § 353 (1994).
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B. Current State Role in Prescription Drug Regulation
State boards or commissions of pharmacy are responsible for the
oversight and licensing of pharmacies and pharmacists.53 State medical
boards within each state license and regulate how physicians and
prescribers write prescriptions.54 These roles of the state boards of
pharmacy and medicine are analogous to the legal profession's state bar
and ethics requirements. In order to be licensed to practice in a state,
pharmacists and doctors must meet that state's licensing requirements.
All fifty states and the District of Columbia have a state medical board or
commission of pharmacy responsible for licensing and regulating all
pharmacies doing business within a state.
Most states also require pharmacies that operate out of state, but that
ship products to consumers within their state, to be licensed by their state
board or commission.55 This may include Internet and mail service
pharmacies.
Many states have enacted statutes to regulate mail-order delivery of
drugs. Forty states currently have codified mail-order pharmacy
requirements, which require a pharmacy to be licensed wherever its
headquarters is physically located and wherever the patients it serves
reside.16  Therefore, mail-order pharmacies must meet each state's
requirements to service customers in more than one state. However,
eleven states have chosen not to enact licensing requirements for out-of-
state mail order pharmacies.57
For example, in the Connecticut statute, a "Non Resident Pharmacy" is
defined as any pharmacy located outside the state of Connecticut which
ships, mails or delivers, in any manner, devices or drugs into Connecticut
pursuant to a prescription order.58 The statute requires registration of the
pharmacy with the state, outlines four criteria that must be met to deliver
drugs into the state and mandates the use of a business hour telephone
number that must be affixed to every prescription drug container
53. See Issue Brief No. 752, supra note 21.
54. See House Hearing, supra note 14 (statement of Carla Stovall, Att'y Gen.,
State of Kansas).
55. See House Hearing, supra note 14.
56. Id. (stating that forty states currently require pharmacies to be licensed
wherever its headquarters are physically located and wherever the patients it
serves reside. This process is somewhat similar to the procedure mail-order
pharmacies undergo to service customers in several states).
57. See, e.g., GAO REPORT, supra note 11 (Mass. and W.Va.).
58. CONN. GEN. STAT. § 20-627(a) (1999).
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dispensed. 9 Other states, such as Alabama, mandate that any nonresident
pharmacy that ships, mails or delivers prescription drugs or devices to a
patient in the state of Alabama shall designate a resident agent in
Alabama for service of process.6° If a resident agent is not designated, the
designee automatically becomes the Secretary of State of Alabama.61
Furthermore, all states statutorily provide that entities illegally
obtaining or supplying drugs by fraud, deceit, misrepresentation,
subterfuge or forgery will face revocation of license, prosecution or
another type of penalty. States enacted these laws to protect their
respective citizens from black-market pharmacies and to ensure consumer
trust, safety and protection by licensed professionals.
Throughout the debate surrounding the creation of the FDCA,
Congress recognized that a state-based pharmacy licensing regulatory
system, as described above, was the best approach. 63 The rationale behind
Congress' decision was that this responsibility fell within the state's police
powers to regulate the health, safety, and welfare of its citizens. Congress
acknowledged that the drug system needed to change from a market
driven arrangement, where consumers were making their own choices, to
a hierarchical structure, where pharmacies and pharmacists controlled
distribution of potentially dangerous pharmaceuticals through
prescriptions.64
In the current evolving marketplace, numerous cyber-drugstores are
easily circumventing the current scheme of regulations. The Internet is
creating a market or consumer driven system remarkably similar to that
existing prior to the enactment of the FDCA. This similarity exists
because consumers now have direct access to drug manufacturers and
drug information through the World Wide Web, which circumvents the
prescriber and the pharmacist. Thus, much of the debate that occurred
during the creation of the current state-based system of pharmacy
regulation is being revisited. The same dangers from which Congress
tried to protect consumers at the inception of the regulatory system are
being revived with current trends. Prescription drug advertisements
targeting consumers and the growth in Internet use are causing the federal
and state governments to re-evaluate the balance of regulatory
59. CONN. GEN. STAT. § 20-627 (b)(1)-(4),(c).
60. ALA. CODE § 34-23-92 (1990).
•61. Id.
62. See, e.g., CONN. GEN. STAT. § 20-627(a) (1999).
63. See TEMIN, supra note 22, at 55.
64. See id.
2000]
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S 61
authority.
II. THE NEW PHARMACEUTICAL LANDSCAPE
Like traditional community pharmacies, Internet pharmacies allow
consumers to order new prescriptions and refill existing prescriptions, to
obtain important information regarding their medication, to receive
prescription refill reminders, and to access their complete medication
profile.66 Internet pharmacy sites represent an alternative electronic
medium for ordering prescriptions, comparable to a fax or telephone."
For example, just as a "patient takes a prescription to a pharmacy, a
physician calls in a prescription, or the patient calls in a refill," patients
can now access the World Wide Web via the Internet to order
prescription medications on-line. 69 The orders can then be delivered by
mail to the consumer or picked up from a local pharmacy. Many on-line
pharmacies are subsidiaries of traditional community or chain drugstore• 70
pharmacies. However, new on-line pharmacies have begun to spring up
because corporations not previously engaged in pharmaceutical
distribution have recognized the potential of the growing market. As a
result, several different business forms have emerged. E-pharmacies can
be strictly on-line or they can form partnerships with more traditional
healthcare entities, including community pharmacies, chain drugstores,
pharmacy benefit managers (PBMs), insurance companies or Health
• • • 71
Maintenance Organizations.
Regardless of the form of the relationship, pharmacies and pharmacists
must be licensed by state boards of pharmacy, and must comply with a
comprehensive set of laws and regulations. Federal and state regulators
are becoming concerned with questionable and unethical pharmaceutical
practices, including prescribing and dispensing drugs through some
65. See House Hearing, supra note 14.
66. See NATIONAL ASSOCIATION OF CHAIN DRUG STORES ISSUE




69. Id.; see generally House Hearing, supra note 14.
70. See http://www.cvs.com (last visited Nov. 8, 2000); http://www.riteaid.com
(last visited Nov. 8, 2000).
71. See Larry Stevens, E-pharmacies A Slow Go - Marketing Prescriptions On
The Web Still Seen As A Big Headache, INTERNETWEEK, Feb. 28, 2000, at
http://www.internetweek.com (last visited Mar. 2000).
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72
Internet pharmacy sites. These sites, labeled "rogue" sites by the FDA,
legislatures, and regulators, may be providing unsafe products or allowing
customers to obtain prescription drugs illegally.73 These sites provide
opportunities for irresponsible marketers to prey on ill consumers, with
74potentially serious consequences.
There are several ways in which the sale and distribution of
pharmaceutical products over the Internet can be categorized.
Traditional "click and mortar" 5 online pharmacies require consumers to
obtain a prescription from a licensed physician before ordering the drug.76
A valid prescription must be submitted, either by the prescriber or
consumer, to the on-line pharmacy by fax, e-mail or phone. The on-line
pharmacy then verifies the prescription with the prescribing physician.
Finally, prescription drugs are either delivered by mail to the consumer or
picked up at a community drugstore that has partnered with the cyber-
drugstore.77 An example of a traditional site is drugstore.com, a site that
is run like the corner drugstore or mail service pharmacy. This site
complies with all current laws of the fifty states and with the federal law
regarding the distribution of pharmaceuticals. 79  The only difference
between the community drugstore and drugstore.com is the manner in
which the company communicates with its customers. 8° Most state and
federal governmental officials believe that on-line drugstores functioning
in the same manner as traditional pharmacies are legitimate, safe, and can
effectively and conveniently distribute prescription drugs to consumers."
A second category of on-line pharmacies offers the services of a doctor
or other prescriber to diagnose and prescribe medication for a patient on-
72. See generally House Hearing, supra note 14.
73. See id.
74. See House Hearing, supra note 14 (statement of Jody Bernstein, Director,
Bureau of Consumer Protection, FTC).
75. Steven, supra note 71.
76. See http://www.drugstore.com (last visited Oct. 4, 2000); E-Drugs-Who
Regulates Internet Pharmacies? Hearing Before the Senate Committee on Health,
Education, Labor, and Pensions, 106th Cong. (2000) [hereinafter Senate Hearing]
(statement of Peter M. Neupert, President and CEO, Drugstore.com); House
Hearing, supra note 14.
77. See id.
78. http://www.drugstore.com (last visited Dec. 17, 2000).
79. See Senate Hearing, supra note 76 (statement of Peter M. Neupert,
President and CEO, drugstore.com).
80. Id.
81. Id. (statements by Sen. Jeffords, Sen. Kennedy, Sen. Dodd, and Kansas
Att'y Gen. Carla J. Stovall).
2000]
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line.82 The website pharmacy then distributes the medication without aS 83
physician ever physically seeing the patient. Typically these on-line
doctor/pharmacies use an on-line medical questionnaire which asks for• • 84
the patient's medical history and a list of current medications. Based on
the answers to these questionnaires, the doctor gives his diagnosis and
prescribes a medication.8' The lack of patient-physician contact, the ease
by which these drugs can be obtained by fraud or unethical review of
medical history, and the potential for people to be harmed by receiving
drugs that may not be suitable or necessary to treat the patients condition,
all raise serious health concerns. 86 For example, some pharmacy sites
focus solely on the prescribing and dispensing of certain lifestyle
enhancing drugs. These medications are often provided without the
benefit of complete patient medical information. Moreover, the
dispensing pharmacy may not even be licensed."' Children, women,
elderly patients with heart conditions, and even household pets are
receiving- incorrect or inappropriate medication, such as Viagra, from on-
line ordering despite the fact that the patient accurately and honestly
completed the on-line form.89  "The ease with which these drugs,
especially the controlled substances, [are] distributed without an exam,
without even a conversation with the recipient, is shocking and should be
terrifying to those invested in public health. '  These websites do not
meet the requirements established by most states for the ethical and legal
practice of dispensing medical advice and prescription drugs.
Illicit on-line pharmacies are a third type of pharmacy site. These sites• • 91
allow consumers to purchase prescription drugs without a prescription.
Alarmingly, these sites even sell narcotics and other equally dangerous
drugs to consumers without any type of authorization from a health92
professional. Sites that allow prescription drugs to be sold without any





87. See House Hearing, supra note 14; for other sites that offer lifestyle drugs,
see http://www.quest.com (last visited Dec. 17, 2000).
88. See House Hearing, supra note 14.
89. See Senate Hearing, supra note 76.
90. Id. (statement of Carla Stovall, Kansas Att'y Gen.).
91. See id. (statement of Ivan K. Fong, Deputy Associate Att'y Gen., U.S.
DOJ).
92. See Senate Hearing, supra note 76.
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pretense of a prescription are clearly violating the FDCA, the FDA
regulatory rules, the CSA, and the laws of all fifty states.
The final category and the hardest for FDA to regulate are "offshore
foreign-based sites." 93 These sites allow foreign-based entities to reach
across international borders to provide medications, which may or may
not be obtained with a prescription, to United States consumers.94 These
sites often provide consumers with experimental treatments not available
in the United States or with drugs not approved by the FDA. Foreign
sites may allow pharmaceutical products to be ordered without a
prescription, and import the products into the United States via mail.95
The problem with these sites is that every country has a different
approval process for prescription drugs. Many countries have less
stringent drug approval processes than the United States. The Internet
allows residents of the United States to access a website of an entity
selling pharmaceuticals in another country that may not meet domestic
health requirements or vice versa.96 These situations raise legitimate
concerns about the quality and safety of prescribing and dispensing
prescription drugs through Internet drugstores. Consumers are at risk
when pharmacy sites either offer prescription drugs or unapproved
fantasy cures that could be dangerous to their health.97
III. GEOGRAPHIC VAGUENESS OF THE INTERNET
The Internet obscures geographic and legal barriers and creates a drug
marketplace without defined borders." Because of the global nature of e-
commerce, it is doubtful whether any individual legal entity can regulate
the Internet. This issue is further complicated by the fact that domain
names, web addresses, location of consumers, and the situs of entities
selling drugs cannot accurately be identified. 9  Congress and state
legislatures want to pass laws protecting consumers from the dangers of
93. Id.
94. Id.
95. See House Hearing, supra note 14; for other sites that offer lifestyle drugs,
see http://www.quest.com (last visited Dec. 17, 2000).
96. A simple example: the U.S. FDA has approved the sale of some strengths
of hydrocortisone without a prescription. England and Ireland on the other hand,
prohibit the over-the counter sale of this drug. Interview with Louise Kingston,
Irish Attorney and Ph.D candidate, in Washington, D.C. (Jan. 20, 2000).
97. See House Hearing, supra note 14.
98. ACLU v. Reno, 521 U.S. 844, 853 (1997).
99. Id.; see Toross, supra note 3; Impact of the Internet, supra note 4; House
Hearing, supra note 14.
20001
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rogue pharmacy websites. However, the inability of regulators to
accurately determine the location of a website and to stop someone from
visiting a site, makes it difficult to do so.' °° Furthermore, because no
boundaries exist, conflicts are created over what legal entity actually has
legal authority to proscribe laws.' Aside from the vast problems created
in the international market and by the transference of data, the borderless
nature of the Internet has also sparked a federalism debate within the
United States.
A. Will Federalism Thrive in the New Frontier?
Since the Constitutional Convention in 1776, two competing
Constitutional theories have emerged within our legal system. The first
theory interprets the Constitution as creating a strong uniform federal
government. The other interpretation reserves certain powers to the
states. "These simple truths of power bestowed and power withheld
under the Constitution have never been more relevant in this day, when
accretion, if not actual accession, of power to the federal government
seems not only unavoidable, but even expedient,"'0 2 especially in light of
the creation of the Internet. However, as President Woodrow Wilson
observed, "[t]he question of the relation of the states to the federal
government is the cardinal question of our constitutional system. At
every turn of our national development we have been brought face to face
with it."'0' 3
In the wake of the Internet revolution, the federalist division of power
in the United States has the potential to be undermined and seriously
diminished. Many legal scholars believe that the federal government is
the only governmental entity that has authority to regulate activity
occurring over the Internet in the United States.'"4 This theory is based
on the Commerce Clause"' and the interstate nature of e-commerce.
However, others follow the theory that the Constitution and legal
precedent have established traditional state roles of regulation, such as
the state police powers, 6 that may be thwarted by technology.
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Thus once again, policy makers are re-examining the allocation of
regulatory power within the federalist system of government.
"Sometimes, a greater reliance on federal standards will be the right
policy choice. Other times, the right policy choice will be to devolve
responsibilities to state and local governments, rather than centralize
them at the federal level."' 7 The growing federal and state regulatory
debate surrounding on-line pharmacies is a prime example of the legal
conflicts created by these two divergent theories regarding the regulation
of Internet activity.
The Constitution of the United States recognizes the authority of the
states, since the states preceded and ratified it and reserved to the states
the authority to regulate the health, safety, and welfare of their citizens.'0 8
The licensing of pharmacies falls within these states rights. It is important
to examine the reasons states were given the power to license and
regulate pharmacies. Traditionally, most pharmacies were operated
within the local communities and only dispensed drugs to citizens in one
particular state or location. States were given the authority to ensure that
pharmacies distributed drugs in a safe manner that protected the health of
its citizens. As discussed earlier, states monitored drug distribution by
enacting professional licensing safeguards. The federal government
concurred with the state-based approach to regulating pharmacy
practices. It was easier for citizens to seek relief through a local or state
government entity rather than through a federal agency. States
established licensing and certification processes to provide professional
standards to ensure consumer safety in many professions outside of the
healthcare area as well. Learned licensed professions, such as lawyers,
doctors, teachers, and pharmacists, are exclusively regulated by each
individual state.
The following cases illustrate the diverging views within the legal
community in relation to federalism and regulation of the Internet. In
1997, the United States District Court for the Southern District of New
York ruled in American Libraries Association v. Pataki'°9 that the Internet
"represents an instrument of interstate commerce"' ' and that the
"novelty of the technology should not obscure the fact that regulation of
the Internet impels traditional Commerce Clause considerations.""1 ' The
district court held that a state Internet Act could not survive Commerce
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Clause scrutiny, "because it places an undue burden on interstate traffic,
whether that traffic be in goods, services or ideas. 112  The judge
renounced all state regulation of the Internet and called for a "uniform
national treatment [that] bars the states from enacting inconsistent
regulatory schemes.
11 3
Three days after Pataki, the Supreme Court of New York also
addressed the jurisdictional issues of the Internet. In New York v.
Lipsitz,114 the court took the position that traditional jurisdictional
standards have proven efficient to resolve civil Internet jurisdictional
issues to date."' The court held that the New York State courts had
jurisdiction over the respondent who sold magazine subscriptions under
both unregistered and registered assumed business names in violation of
existing state consumer fraud statutes.11 6  "The Internet medium is
essentially irrelevant, for the focus is primarily upon the location of the
messenger and whether the messenger delivered what was purchased."
'1 7
"Where a person. . . conducts a business within the forum state by being
a subscriber to a local Internet service provider and selling a product
through that provider, jurisdiction is proper."1 8 The New York State
court focused on the transaction involved and not the venue or medium in
which it was purchased.
The New York court distinguished Pataki from Lipsitz on two grounds.
First, state consumer protection laws are applicable to the conduct of a
local business and were not designed nor aimed at regulating conduct
outside the state's borders." 9 Second, the law at issue in Lipsitz was not
120designed to create an Internet regulatory scheme. In dicta, the court
stated that:
The claims are of local concern, as recognized by the nationwide
system of state consumer protection laws. There is no
112. Id.
113. Id. at 184.
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compelling reason to find that local legal officials must take a
"hands off" approach just because a crook or a con artist is
technologically sophisticated enough to sell on the Internet.
Invocation of "the Internet" is not the equivalent to a cry of
"sanctuary" upon a criminal's entry into a medieval church. It
should be sufficient that the laws sought to be applied, even if
they might tangentially implicate interstate commerce, are
"media neutral" and otherwise pass constitutional muster.2 1
The distinction is that Lipsitz dealt with an existing state law being
applied to the Internet, while Pataki tested a law targeted directly at the
Internet. This same distinction would logically apply to regulation of
prescription drugs over the Internet.
Just because there is now a new medium in which illegal acts can occur
does not mean we throw out the baby with the bath water; in other words
an otherwise illegal act does not become legal merely because it is
committed using technology and the Internet.23 A state does not become
powerless to protect its citizens merely because a threat to the health and
welfare of its citizens arises on-line rather than in person, by mail, or in
some other traditional manner. 124 Therefore, states should be able to
apply existing state licensing and consumer protection laws to on-line
pharmacies. The traditional role and function of state government is to•* 125
protect the health, welfare, and safety of its citizens. What greater
function does a state hold than to maintain solid health care protections
by regulating the dissemination of drugs? In fact, states have traditionally
maintained these standards and have uniquely packaged them to address
local community concerns.121
Over the last few years, the Supreme Court has reminded Congress
that federalism still exists in the United States and that the federal
government and state governments have distinct and separate roles."'
More recently, the court has upheld state criminal codes, and the right to
118regulate schools and school grounds.
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Inherently, Internet commerce falls under interstate commerce because
it crosses state lines. Proponents of federal commerce clause jurisdiction
believe that the government needs to streamline regulation and erode the
federalism theory of government. These scholars maintain that it is not
cost-effective to have fifty superfluous licensing requirements across state
lines. 9  They argue that it creates redundancy by maintaining fifty
separate state efforts to achieve a similar or identical goal. 3 ' Moreover,
repetitive state laws can exact costs associated with multiple adjudication
of what is essentially one issue addressed by the separate laws of
numerous states.'3 ' In addition, industries, which must comply with
numerous licensing laws, may have duplicative and costly state
compliance fees that may impose a conflict of laws upon a single actor for
a single transaction because of state-by-state differences. 112 Advocates for
a stronger federal role in pharmacy regulation and oversight argue that a
traditional mail-order pharmacy can expand its operations on a state-by-
state basis as it obtains licenses for each state in which it does business.1
33
A start-up Internet pharmacy is by its very nature nationwide on the day
it opens for business. Unless an on-line pharmacy obtains all necessary




The uniformity argument is minimized by the fact that legitimate mail-
order pharmacies have been complying with state licensing and consumer
laws since their inception. It follows that legitimate cyber-drugstores can
also comply with state licensing laws by not delivering drugs into states in
which it does not have a license. Teachers, doctors, and lawyers must be
licensed or certified in each state in order to practice their professions.
This licensure principle is one that needs to be maintained for pharmacists
and pharmacies as a mechanism to uphold ethical and safety standards.
Throughout the history of the United States, the conflicting views of
federalism have remained balanced. Technology should not be the
downfall of our federalist society. One commentator suggested that "the
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law as presently constituted will absorb the challenges posed by the
Internet, as the law has absorbed challenges posed by previous
technological innovations."'36 Governance in a federalist-Internet society
entails compromise and partnership to ensure that protections are in place
for a community's citizens and businesses.
B. Federalism as a Partnership
The partnership approach is based on a hybrid of the two divergent
federalism theories. The federal government has the authority to use its
Commerce Clause power to create legal mechanisms that recognize and
facilitate state regulation and the licensing of professional entities that
traditionally fall within state jurisdiction.
This is not a remote or shocking legal principle. Congress
demonstrated its ability to partner with states when it enacted the federal
telemarketing statute.'37  The federal telemarketing statute138 gave the
states the power to seek nationwide injunctive relief by filing suit in
federal district court. 139  This provision enables a state, through its
attorney general, to obtain an injunction effective nationwide, and yet
does not prohibit action in state court based on individual state law."'
The States' Attorneys General are advocating this position as a way to
enhance enforcement of existing law to combat lawlessness occurring on
the Internet.14 ' This approach would enable states to avoid duplicative
enforcement proceedings against alleged illegal cyber-drugstores.
As the Lipsitz court inferred, existing laws are applicable to citizens
using the Internet. 4 2 Thus, rather than creating new authority for on-line
pharmacies, states should look to existing statutes, not related to the
Internet medium, for enforcement against criminal activity on the
Internet. The federal government can take steps to assist state efforts by
instituting national injunctive relief, thus forcing the industry to
strengthen advertising and disclosure requirements.
136. Scheppach & Shafroth, supra note 103.
137. Telemarketing and Consumer Fraud and Abuse Prevention Act, 15
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IV. ENFORCEMENT OF EXISTING LAWS TO ON-LINE PHARMACIES
According to testimony at the first Congressional hearing on the
dangers of on-line pharmacies, all of the witnesses stressed that pre-
existing laws can be applied to lawlessness on the Internet. 143 Currently,
each state has the statutory authority to obtain a restraining order
preventing unlicensed on-line pharmacies from doing business within a
state's own borders." Twenty states have already taken action against
illegitimate on-line prescribers and distributors through pre-existing state
laws. 45
New Jersey charged eight on-line pharmacies with consumer fraud
violations for selling prescription medications via the Internet without a
state license.146 New Jersey law requires pharmacies, pharmacists, and
physicians practicing in the state to be licensed with the New Jersey
Division of Consumer Affairs. The cyber-drugstores against which the
state has brought suit are unlicensed entities in the State of New Jersey.
The State alleged that the on-line pharmacies violated the state Consumer
Fraud Act and committed an unconscionable commercial practice for
failing to disclose to New Jersey consumers that they were not licensed to
dispense prescription drugs or controlled dangerous substances in the
state.
In Kansas, the Attorney General filed suit against eight on-line
companies, six doctors, and four additional persons for participating in the
illegal sale of prescription drugs to Kansans. 49 The Internet drugstores
were unlicensed and required no in-person examination or consultation
prior to prescribing and dispensing drugs. 5° The Attorney General based
the case on the premise that
by prescribing drugs to Kansans, [the doctors] practiced
medicine [in Kansas] without the required legal authority. By
dispensing drugs to Kansans, [the defendants] practiced
pharmacy in the state without the required legal authority. And
143. See generally House Hearing, supra note 14.
144. See Senate Hearing, supra note 76 (statement of Carla Stovall, Kansas
Att'y Gen.).
145. Id.; GAO REPORT, supra note 11.
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by recklessly dispensing drugs without any doctor-patient
relationship whatsoever, while failing to disclose to consumers
material information, such as health risks associated with use of
some of these drugs, all of the defendants committed deceptive
and unconscionable acts in violation of our Consumer
Protection Act.' 51
Other states, such as Texas, West Virginia, Wisconsin, Missouri,
Washington, and Maryland are also enforcing existing laws against
Internet pharmacies illegally dispensing drugs to their respective
citizens.12 "Most of the Internet pharmacies that were sued voluntarily
stopped shipping prescription drugs to consumers in those states."'53 As a
result, eighteen cyber drugstores stopped shipping drugs to residents in
Illinois, Kansas, Michigan, Missouri, New Jersey, and Pennsylvania.
States are stopping the unlicensed cyber-pharmacies from doing
business in their states and are seeking financial penalties and
investigative costs. However, when a state successfully prosecutes an
Internet pharmacy and prevents the pharmacy from dispensing drugs to
residents of its state, the court action applies only in that state. By
extending nationwide injunctive relief, states would be able to combine
efforts and resources against the same bad actors, while leaving other
states free to use limited resources to file against other offenders.
States that have not specifically taken action against Internet
pharmacies also have existing laws that are enforceable. Statutes, such-as
the Connecticut mail-order statute discussed earlier, allow all inclusive
dispensing, i.e. "in any manner,"'55 and thus are far reaching enough to
incorporate the purchase and sale of drugs by and to Connecticut citizens
over the Internet.
The federal government has set the precedent for applying already
existing laws to sales over the Internet."' Since 1996, the FDA has started
enforcing existing FDA regulations and laws against entities selling drugs
over the Internet.' The FDA has been successful in using current wire
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individual was convicted on wire fraud charges stemming from the use of the
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fraud laws, which formerly only applied to telephone and facsimile, to
convict individuals for illegally selling unapproved medical products over
the Internet.
5 8
As previously discussed, Congress granted the FDA express authority'"
to regulate information and direct consumer advertising of prescription
drugs.'6° Prescription drug advertising must contain the established name,
list of ingredients, and a brief summary. of side effects and any other
information specified by regulation. 6 ' The FDA, in its implementing
regulation, construes the statutory provision broadly to include
"advertising in published magazines, other periodicals, newspapers, and
broadcast media such as radio, television, and telephone communication
systems. ,16' The FDA has not indicated whether these advertising
regulations will encompass Internet sales and advertising. However, the
fact that the FDA has expressed an interest in stricter enforcement, might
Internet to sell an illegal medical product. Previous wire fraud charges involving
illegal medical products were based only on telephone and facsimile use. In
November 1998, an Illinois drug overdose case OCI assisted in identifying the
subject's source of supply as an Internet site in Canada.; OCI was advised by a
State Board of Pharmacy that an internet site was offering prescription drugs to
U.S. customers from foreign manufacturers, by acting as authorized "buyers club"
using the "personal importation" policy of FDA. The FDA in coordination with
Customs Service (USCS) used high tech surveillance of the suspect and revealed a
sophisticated operation centered out of an apartment building. OCI and USCS
arrested the suspect and he was sentenced in federal court.
158. 18 U.S.C. § 1345 (2000) ; 21 U.S.C. § 332 (2000); see also House Hearing,
supra note 14 (statement of Ivan K. Fong, Deputy Assistant Att'y Gen., U.S. DOJ
and statement of Dr. Janet Woodcock, FDA). "As of September 1, 2000, 11
Internet pharmacies had been certified by NABP and 25 others had applied for
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U.S.C.).
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161. 32 GA. L. REV. 141., citing 21 U.S.C. 352(n) (1994) (providing that a
prescription drug shall be deemed to be misbranded "unless the manufacturer,
packer, or distributor thereof includes in all advertisements . . . such other
information in brief summary relating to side effects, contradictions, and
effectiveness as shall be required in regulations"). The Federal Trade
Commission (FTC) retained jurisdiction over the advertising of nonprescription
drugs. See 36 Fed. Reg. 18,539 (1971) (announcing applicable memorandum of
understanding between the FDA and FTC); Thompson Med. Co. v. FTC, 791 F.2d
189, 192-93 (D.C. Cir. 1986) (holding that FDA review of labeling claims for
nonprescription drugs did not prevent FTC enforcement action against advertising
claims for such products.).
162. 21 C.F.R. § 202.1(1)(1) (1997).
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lead the agency to include the on-line medium.' The FDA may start to
enforce and regulate a pharmaceutical company's content on a website to
conform to non-website standards.
The Federal Trade Commission (FTC) also has authority to protect
consumers from on-line pharmacies. It may bring actions against specific
deceptive practices that involve a misrepresentation or omission likely to
mislead consumers.' 64 Thus, the FTC could bring an enforcement action
where an on-line pharmacy makes false or misleading claims about the• 165
products or services it provides. The FTC also has under its unfairness
jurisdiction the authority to "regulate marketing practices that cause or
are likely to cause substantial consumer injury, which is not reasonably
avoidable by consumers, and not outweighed by countervailing benefits toS. .,166
consumers or to competition."
These are examples of existing federal authority that do not explicitly
regulate the Internet medium but can encompass entities doing business
on the Internet. Moreover, not only can existing laws apply to the
Internet, but the private sector also plays a role in regulating business on
the Internet.
In response to public, state and federal regulatory agency concerns
regarding the safety of pharmacy Internet prescribing and dispensing
sites, The National Association of Boards of Pharmacy (NABP)
developed a Verified Internet Pharmacy Practice Site (VIPPS). 167 This is
a voluntary certification program for on-line pharmacies that wish to post
the VIPPS seal of approval on their website."6  It combines the
"mandatory requirements of state regulation with Internet practice
standards developed by an expert panel of providers, federal agencies,
and state regulators."' 69 The certified program is designed to provide
163. See House Hearing, supra note 14 (statement of Dr. Janet Woodcock,
FDA).
164. See 15 U.S.C. § 45 (2000). Section 5 of the Federal Trade Act (FTC Act)
enables the FTC to prevent deceptive or unfair acts or practices in commerce. See
also House Hearing, supra note 14 (statement of Jody Bernstein, Director, Bureau
of Consumer Protection, FTC).
165. See House Hearing, supra note 14 (statement of Jody Bernstein,
Director, Bureau of Consumer Protection, FTC).
166. Id.
167. National Association of Boards of Pharmacies: Frequently Asked
Questions, at http://www.napb.net/vipps/faq.asp (last visited July 2000)
[hereinafter NABP].
168. Id.
169. See generally House Hearing, supra note 14 (statement of Carmen
Catizone, Exec. Director, Nat'l Ass'n of Board Pharmacies).
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consumers with vital information regarding on-line pharmacy licensure
compliance. 170 The seal can be compared to the Good House Keeping
Seal that notifies a consumer that the product is approved, legitimate, and
can be used safely. Likewise, the VIPPS seal informs consumers that a
site is complying with safety licensing standards and is a legitimate place
to do business.
The Internet sites that receive this seal must demonstrate compliance
with all mandatory licensure, statutory, and regulatory requirements of
state practice acts.17' The NABP independently verifies this compliance
directly with the states through its clearinghouse and onsite inspection of
the site and affiliated facilities. 7 1 "After all of the information is verified,
and meets NABP's requirements, the site will be listed on NABP's web
site and given permission to display the VIPPS Seal.' ' 7 3 The Seal includes
a hyperlink to the NABP site to protect the integrity of the NABP seal.
The NABP site will state if the pharmacy site is verified. 174 NABP has an
elaborate security system in place to avoid misrepresentation or
inappropriate duplication of the NABP VIPPS seal.175  This industry
certification program is one that resembles the legal practice's
professional code of conduct, which has created a self-policing
professional industry.
The cooperation already occurring between the pharmacy industry, the
states and the federal government is overwhelming evidence that the
existing state-based structure of pharmacy practice can be applied to on-
line pharmacies through a partnership that upholds federalism. Congress
may need to evaluate and enhance existing federal and state laws to
facilitate effective enforcement of questionable cyber-drugstore activity.
One example of federal enhancement, discussed earlier, gives states the
power to enforce national injunctive relief in federal district court. There
may be other methods of enhancing existing law, such as explicitly
creating legal requirements pertaining to information displayed on a
pharmacy site and continuous coordination of the industry clearinghouse
for all legal cyber-drugstores. However, Congress must use caution in its
approach. The partnership approach, which encompasses coordination
170. See NABP, supra note 167.
171. See House Hearing, supra note 14 (statement of Carmen Catizone, Exec.
Director, Nat'l Ass'n of Board Pharmacies).
172. Id.
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Director, Nat'l Ass'n of Board Pharmacies).
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between the states, the federal government, and the pharmacy industry, is
the key to ensuring safety standards and education of the consumer.
CONCLUSION
Much of the debate that occurred when Congress enacted the FDCA
and the establishment of the current state-based approach to regulating
pharmacy practice is being revisited in the debate surrounding regulation
of on-line pharmacies. While cyber-drugstores have renewed public focus
and health professionals' concern over the drug distribution system, it is
imperative to remember that for more than sixty years federal and state
regulators have been working successfully within oversight structures to
ensure the quality and integrity of the prescribing and dispensing176
process. The fact that Congress answered the original debate with a
state-based approach should make the current debate simpler.
The starting place should be to remain within the boundaries already
imposed on citizens and the medical profession. The Internet has
nonetheless created a different type of market from which consumers (1)
purchase prescription drugs, (2) access more information, and (3) search
for cheaper prescriptions. The federal government should continue to
regulate advertising, safety, and classification of drugs and eventually may
need to extend this regulatory power to the website pharmaceutical
companies. However, Congress should be very cautious not to put too
much power into the hands of the federal government and the FDA.
Although the Internet almost undoubtedly falls under the Commerce
Clause, illegal activity occurring over the Internet does not change merely
because of the new medium in which it occurs.
In order to maintain a balance of power, the best approach is a
partnership in which states are allowed federal injunctive relief against
on-line pharmacies that break existing laws. The federal government
needs to ensure consumer protection through education of residents of
the United States about the dangers associated with cyber-drugstores so
that consumers are better informed. A partnership between the industry,
the state boards of pharmacy, the State's Attorneys General's offices and
the federal government makes the most sense. Congress should make
adjustments to the current state-based drug distribution system but not
completely overhaul an adaptable framework.
176. See generally House Hearing, supra note 14.
20001

